Optimizing Immunization Agenda 2030 (IA2030) implementation to support achievement of Global Strategy to Eliminate Yellow fever Epidemics (EYE) objectives

The Immunization Agenda 2030 (IA2030) lays out a framework relevant to all vaccine-preventable diseases and provides the orientation for global priorities in the upcoming years through 2030. Embedded in the IA2030 approach is the specific mention of disease-specific programmes for high impact epidemic prone diseases with their own initiatives including the Global strategy for Elimination of Yellow fever Epidemics (EYE).

The EYE leadership group (LG) recognizes the importance of EYE within the IA2030 context and requested analysis to identify areas of shared priorities and interest between EYE and IA2030 to maximise the impact of yellow fever (YF) control activities. Specifically, the LG requested the EYE partnership clearly define and leverage areas of intersect between EYE and the IA2030. This mandate for core partners to formally assess the implications and intersects of EYE with the IA2030 led to the creation of the ad hoc task team (TT). The TT was requested to review IA2030 and identify how the EYE Strategy interprets itself through the IA2030 seven strategic priorities and the four core principles that drive the priorities, and how EYE can strengthen linkages with other vaccine-preventable disease initiatives and programmes. In addition, the LG requested the TT initiated exploratory analysis and dialogue on the eventual exit strategy for the EYE Strategy at the end of the 10-year course of the strategy in 2026.